Parnassus Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.2M | Buy |
+37,412
| New | +$12.2M | 0.03% | 122 |
|
|
2024
Q2 | – | Sell |
-38,748
| Closed | -$5.79M | – | 130 |
|
|
2024
Q1 | $5.79M | Hold |
38,748
| – | – | 0.01% | 120 |
|
|
2023
Q4 | $7.42M | Hold |
38,748
| – | – | 0.02% | 114 |
|
|
2023
Q3 | $6.86M | Buy |
+38,748
| New | +$6.86M | 0.02% | 119 |
|
|
2022
Q4 | – | Sell |
-25,970
| Closed | -$5.2M | – | 138 |
|
|
2022
Q3 | $5.2M | Sell |
25,970
-32,068
| -55% | -$6.42M | 0.01% | 126 |
|
|
2022
Q2 | $8.47M | Sell |
58,038
-19,549
| -25% | -$2.85M | 0.02% | 124 |
|
|
2022
Q1 | $12.7M | Hold |
77,587
| – | – | 0.03% | 128 |
|
|
2021
Q4 | $13.2M | Hold |
77,587
| – | – | 0.03% | 121 |
|
|
2021
Q3 | $14.6M | Hold |
77,587
| – | – | 0.03% | 119 |
|
|
2021
Q2 | $13.2M | Hold |
77,587
| – | – | 0.03% | 119 |
|
|
2021
Q1 | $11M | Hold |
77,587
| – | – | 0.03% | 121 |
|
|
2020
Q4 | $10.1M | Buy |
+77,587
| New | +$10.1M | 0.03% | 110 |
|